Navigation Links
The Women's Heart Health Initiative announces creation of new women's cardiology research fellowship
Date:12/22/2008

New York, NY December 22, 2008 The Women's Heart Health Initiative at the Cardiovascular Research Foundation (CRF) will announce the creation of a new fellowship dedicated to gender-specific research that will improve the prevention, diagnosis and treatment of heart disease in women. The announcement will take place during a February luncheon featuring Mehmet C. Oz, MD.

"Women face unique challenges to successful diagnosis and treatment of heart disease because they develop different forms of the disease than men," said Alexandra J. Lansky, MD, Director of the Women's Heart Health Initiative, "Recommendations for the diagnosis and treatment of heart disease have historically been based on studies conducted primarily in middle-aged men. Most current trials continue to enroll too few women to determine if tests and treatments work equally well in both sexes. By establishing a research fellowship dedicated to gender-specific research, the Women's Heart Health Initiative hopes to identify treatments and preventive strategies that are effective in women and improve the outcomes and quality of life of women with or at risk for heart disease."

The Art of Living Well: A Woman's Guide to Preventing Heart Disease will take place on Wednesday, February 11, 2009 at Tavern on the Green in New York City. Dr. Mehmet C. Oz, one of America's leading physicians, will be the Keynote Speaker and lead this meaningful, in-depth discussion.


'/>"/>

Contact: Judy Romero
jromero@crf.org
212-851-9311
Cardiovascular Research Foundation
Source:Eurekalert

Page: 1

Related medicine news :

1. Womenshealthchannel Enhancements Support Pregnant Teens
2. Drug for cluster headaches may cause heart problems
3. Use of certain lipid measures not more effective in predicting coronary heart disease
4. Restricting Blood Flow May Help Heart Bypass Patients
5. Urban Smog Tough on Young Adults Hearts
6. Stanford study highlights cost-effective method of lowering heart disease risks
7. Vitamin Es lack of heart benefit linked to dosage
8. Drug That Lowers Resting Heart Rate Being Tested
9. Heart Attack Boosts Diabetes Risk
10. Embryonic Stem Cells Repair Human Heart
11. U of M study: Early treatment can reverse heart damage
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... April 28, 2017 , ... An April 24th article on Yahoo! Beauty discusses ... with the help of a weight loss surgery. The woman, declaring “I will not hate ... been left following her dramatic weight loss. Dr. Feiz & Associates notes that, while it ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... its new partnership with the Home Care Association of America (HCAOA). This agreement ... Private Duty Accreditation services, as well as discounts on Accreditation University (AU) educational ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... to announce the integration of Microsoft(R) Word(TM) Online(TM), which enables sleep physicians to ... since it streamlines the reporting process and provides a familiar interface that does ...
(Date:4/28/2017)... ... ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) announced today that ... as “stable.” At the same time, the ratings agency cautioned that the company’s rating ... “capital adequacy” thresholds required for its strong rating. , “Horizon is committed to being ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, Inc. announced today ... throughout the Northeast U.S. , GlycoMark is the only clinically available blood ... provides a clinically proven one- to two-week measure of hyperglycemic excursions, often related ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017  Cogentix Medical, Inc. (NASDAQ: ... providing the Urology, Uro/Gyn and Gynecology markets with ... Keswani has joined the Company as Senior Vice ... created position, Mr. Keswani will report directly to ... "Our organization is delighted that Ash has ...
(Date:4/20/2017)...  RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage ... unmet medical needs, today announced that it will ... development program, based on its proprietary self-delivering RNAi ... (SID) 76 th Annual Meeting.  The SID ... relevant to skin health and disease through education, ...
(Date:4/20/2017)... April 20, 2017  AbbVie (NYSE: ABBV), a ... (n=145/146) of chronic hepatitis C virus (HCV) infected ... 6 and compensated cirrhosis (Child-Pugh A) achieved sustained ... ) with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir ... seen following 12 weeks of G/P treatment without ...
Breaking Medicine Technology: